TUSC2 loss was first identified in gliomas by Xin et al. in 2015, who found that TUSC2 protein expression was significantly decreased in higher grades of glioma when compared to normal brain tissues, with grade IV GBM having the lowest TUSC2 expression (Figure 2) [93]. The gene discussed is TUSC2; the disease is central nervous system cancer.